Fibrinolytic response to acute exercise in patients with peripheral arterial disease

Med Sci Sports Exerc. 2001 Feb;33(2):214-9. doi: 10.1097/00005768-200102000-00007.

Abstract

Purpose: Elevations in tissue plasminogen activator (tPA) are postulated to protect against atherothrombotic events during exercise. However, fibrinolytic response to repetitive bouts of symptom-limited exercise is unknown in peripheral arterial disease (PAD) patients, a population with impaired fibrinolysis and increased risk for ischemic events. The purpose of the present study was to evaluate the fibrinolytic response to repetitive bouts of symptom-limited exercise in PAD patients.

Methods: Nine (8 male, 1 female) patients with Fontaine State II PAD were studied. Fasting blood samples for determination of tPA and plasminogen activator inhibitor (PAI-1) were obtained into an acidified citrate solution via an indwelling venous catheter before, immediately after, 30 min after, and 60 min after submaximal treadmill walking. Patients walked intermittently at 65% of maximal intensity achieved on a previous graded exercise test until 30 min of exercise was achieved.

Results: Exercise increased tPA activity by 180% (0.5 +/- 0.16 IU.mL(-1) baseline, 1.4 +/- 1.2 IU.mL(-1) postexercise), and decreased PAI-1 activity by 40% (20.6 +/- 5.5 AU.mL(-1) baseline, 11.8 +/- 6.2 AU.mL(-1) postexercise), without changing tPA or PAI-1 antigen. Notably, plasma tPA activity levels 1 h after exercise remained elevated by 80%, whereas PAI-1 activity remained decreased by 49%. The decrease in PAI-1 significantly (P < 0.05) correlated with oxygen uptake (VO(2)) during submaximal exercise (r = -0.77).

Conclusion: These findings demonstrate that repetitive bouts of symptom-limited exercise produce a substantial improvement in the fibrinolytic profile of PAD patients, which persists at least 1 h after exercise cessation.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Arterial Occlusive Diseases / complications*
  • Arterial Occlusive Diseases / pathology
  • Exercise / physiology*
  • Female
  • Fibrinolysis / physiology*
  • Humans
  • Intermittent Claudication
  • Male
  • Middle Aged
  • Plasminogen Inactivators / biosynthesis
  • Plasminogen Inactivators / pharmacology*
  • Tissue Plasminogen Activator / biosynthesis
  • Tissue Plasminogen Activator / pharmacology*

Substances

  • Plasminogen Inactivators
  • Tissue Plasminogen Activator